Zydus Lifesciences Sees 26.38% Surge in Open Interest Amid Price Decline

Zydus Lifesciences Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant increase in open interest (OI) today. The latest OI stands at 19,060 contracts, marking a notable rise of 3,979 contracts or 26.38% from the previous OI of 15,081. This surge in OI coincides with a trading volume of 27,599 contracts, indicating heightened activity in the derivatives market. In terms of price performance, Zydus Lifesciences has underperformed its sector by 1.37%, with the stock experiencing a decline of 2.75% over the last two days. Today, the stock reached an intraday high of Rs 998, reflecting a gain of 2.71%, while it also touched a low of Rs 952.2, down by 2.01%. The weighted average price suggests that more volume was traded closer to the lower end of the price range. Despite being above the 200-day moving average, the stock remains below the 5-day, 20-day, 50-day, and 100-day moving averages. Additionally, delivery volume has decreased by 35.19% compared to the 5-day average, indicating a decline in investor participation. Overall, Zydus Lifesciences continues to navigate a challenging market environment, as reflected in its recent performance metrics.